Dana sells ISIS 23.58: Isis Reports Financial Results and Highlights for First Quarter 2014
CARLSBAD, Calif., May 6, 2014 -- /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 ... ...
58 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home